PODOCYTE STRUCTURE AND FUNCTION
Podocytes are highly differentiated epithelial cells that contribute to the size-selective nature of the glomerular filtration barrier (reviewed in [1] ). Major processes extend from the cell body and branch out as foot processes which adhere to the GBM (glomerular basement membrane) and establish an interdigitating pattern with a foot process from a neighbouring cell. In 1974, the elegant studies of Rodewald and Karnovsky [2] first described a zipper-like molecular diaphragm that spans the gap between opposing foot processes. Almost 25 years passed until seminal work by Tryggvason and co-workers [3] identified nephrin as the integral protein that accounted for the filtration slit. Following this discovery, an explosion of work has refocused attention upon the podocyte and its role within the glomerular filtration barrier. Indeed, we now know the identity of a number of gene products that participate in the assembly of the foot processes and slit diaphragm ( Figure 1 ). In addition to nephrin, other proteins, such as CD2AP (CD2-associated protein), canonical TRPC6 [TRP (transient receptor potential) channel 6], podocin, P-cadherin, α-and β-catenin, ZO-1 (zonula occludens-1) and NEPH1, co-localize within this unique and highly specialized subcellular domain to form a modified adherens junction to establish the molecular sieve known as the slit diaphragm.
Figure 1 Key molecular components of the podocyte
Two interdigitating foot processes are shown emphasizing the following structural and functional regions of interest: cytoskeletal components, adhesion complexes and slit diaphragm. Additional gene products include, PGr (prostaglandin receptor) subtypes and podocalyxin, along with its interacting partners NHERF-2 and ezrin. V, vinculin; T, talin; P, paxillin.
The maintenance of the slit diaphragm complex is critical in the sieving qualities of the glomerular filter. Indeed, a large volume of data has emerged indicating reduced expression of these proteins associated with the onset of many glomerular diseases. Furthermore, the health of the slit diaphragm complex is inextricably tied to the internal scaffolding network of the podocyte: the actin cytoskeleton. This cytoskeleton not only establishes and maintains podocyte morphology, but anchors the slit diaphragm complex via a network of proteins, the intermediate filament proteins vimentin [4] [5] [6] [7] and desmin [8] , in the cell body and a microfilament-based contractile apparatus composed of actin, myosin-II, α-actinin, synaptopodin, paladin, talin and vinculin in the foot processes. This cytoskeleton is anchored to focal adhesions along the sole of the foot process via an α3β1 integrin complex, which in turn fastens the podocyte to the underlying GBM [9] [10] [11] . Alterations in cytoskeletal function may underlie the characteristic changes to podocytes observed in the earliest stages of many glomerular diseases, including foot process effacement, cell hypertrophy, pseudocyst formation, cytoplasmic overload with resorption droplets, apoptosis and detachment from the GBM. The retraction and effacement of the podocyte foot processes yields a diffuse cytoplasmic sheet along the GBM. The slit diaphragm ceases to exist when foot processes are effaced. Thus the podocyte cytoskeleton determines the unique morphology of these cells and is critically related to their sieving function.
Treatment options for those affected by glomerular disease are few. Once the initial podocyte modifications have progressed to sclerotic lesions, therapies are aimed at limiting proteinuria and slowing the progression of renal fibrosis in order to avoid ESRD (end-stage renal disease). Present treatment may entail corticosteroids, diet modification, ACE (angiotensin-converting enzyme) inhibition or immunosuppression [12] to reduce hypertension/proteinuria encountered with some individuals. However, many forms of glomerular disease are steroidresistant and dietary compliance is often unreliable. Moreover, recent evidence from genetically induced rodent FSGS (focal segmental glomerulosclerosis) models suggests that podocyte loss exceeding 40 % signals irreversible progression, whereas lower attrition (20 %) yields chronic albuminuria without scarring [13] . This suggests that early intervention is imperative for prevention (i.e. at the initial stages of podocyte damage), whereas the limited options for treatment demand that a more substantial understanding of how podocytes become damaged be provided.
Manipulating the mouse podocyte
The podocyte exhibits a remarkably unique gene expression profile, one that greatly facilitates the generation of transgenic and/or gene-targeted mice. This has allowed investigators to harness a variety of promoters to drive transgene expression in a podocyte-specific manner, with relatively insignificant activity elsewhere. In contrast, consider the glomerular mesangial cell which has long been associated with the progression of numerous glomerular disease processes (e.g. diabetic nephropathy). The identification of promoters offering mesangium-specific activity has consistently eluded the renal researcher. As a result, identifying the role(s) of countless gene products in the context of the mesangial cell in health and disease has proved challenging.
During the last two decades, we have witnessed the emergence and subsequent refinement of strategies for manipulating the mouse genome. The associated technical skills, initially available to relatively few researchers, have become widespread, affordable and even routine, as evidenced by the existence of core transgenic mouse facilities at virtually every research institution. A thorough discussion of the technical aspects of murine gene-targeting and transgenics is beyond the scope of this review; however, a brief discussion of a few approaches is warranted (Figure 2 ).
The so-called 'gene-targeted' mouse ( Figure 2A ) involves the insertion of a fragment of a gene of interest into the allelic locus by homologous recombination in murine ES (embryonic stem) cells. In this way, a gene can either be interrupted (i.e. knocked-out) or a mutation introduced into its coding sequence (i.e. knocked-in) and the impact upon a relevant biological end point assessed. Podocyte-specific promoters have also been harnessed to generate transgenic mice which overexpress genes of interest ( Figure 2B) . A clear disadvantage of the conventional gene-targeting approach is that deletion of the gene of interest (or insertion of the mutation) is accomplished in all tissues and may thus prove to be embryonic lethal if its function is essential for early development. To circumvent this problem, conditional gene-targeting has been adopted to allow for gene manipulation in mice in a tissue-specific manner ( Figure 2C ). Indeed, a number of laboratories have used promoter sequences of the nephrin or podocin genes to generate podocytespecific Cre recombinase mouse lines [14, 15] . Others have refined the Cre/lox system to allow for temporal control over gene expression/activity by engineering doxycycline-inducible podocyte-specific expression of Cre recombinase ( Figure 2D ) [16] .
Finally, novel strategies may be amenable to the podocyte, including shRNA (short hairpin loop RNA)-mediated knockdown of gene products in vivo. This elegant method has seen widespread use in cell culture, and it appears that the Cre/lox system may be adapted to allow for tissue-specific shRNA expression in mice ( Figure 2E ) [17, 18] . An shRNA-based approach obviates the need for time-consuming gene-targeting steps and instead relies upon the relatively straightforward generation of two separate transgenic mouse lines. Other methods on the horizon include infection of mice with adeno-associated viruses or lentiviruses which could encode siRNAs (small interfering RNAs). However, a number of technical hurdles must be cleared before such reagents find a use for the manipulation of podocyte genes in rodents. Foremost among these is the accessibility of the podocyte within the glomerular capillary to virus. Using this growing list of strategies to study gene function in vivo, it will be exciting to see how the podocyte researcher will advance our understanding of disease processes.
PODOCYTE MOLECULES: INSIGHTS FROM MICE
The recent identification of podocyte-specific gene products has refocused investigations towards the podocyte and its role in health and glomerular disease. The objective of the next section of this review is to highlight how animal models have contributed to shaping our understanding of the podocyte.
Slit diaphragm and associated proteins
The role originally ascribed to the slit diaphragm was that of a physical sieve able to prevent passage of protein (i.e. albumin) into the urine. Ample evidence in humans and in rodents supports this view; however, recent findings suggest that the role of the slit diaphragm may be more complex, as signalling mechanisms originating from this structure have been identified which could regulate podocyte function.
Nephrin
Nephrin, encoded by the NPHS1 gene, is a member of the Ig superfamily of proteins. The eight extracellular IgG-like domains of nephrin facilitate protein-protein interactions within the slit diaphragm. Tryggvason and co-workers [3] identified mutations in the NPHS1 gene as the underlying cause of CNF (congenital nephrotic syndrome of the Finnish type). The indispensable role of nephrin at the slit diaphragm was shown further by the development of nephrin-null mice, which displayed massive proteinuria and died within 24 h of birth [19] . Nephrin-null mice exhibit podocyte foot process effacement and a complete loss of a functional slit diaphragm. Elegant studies using electron tomography later demonstrated that the slit diaphragm is a network of molecular strands, which is completely lost in patients 16 ) under control of a podocyte-specific promoter; and (iii) a transgenic mouse expressing Cre-recombinase under the control of the a promoter containing Tet-operator sequences. When the three lines are intercrossed, Tet is given to the mice in the drinking water. In the presence of Tet, a transactivator is becomes active and induces Cre-recombinase expression in the podocytes to excise the 'floxed' gene sequence. (E) shRNA-mediated gene knockdown in the mouse. In this approach, transgenic mice are developed using a construct that contains an shRNA designed against the gene of interest cloned downstream of the U6 promoter. This promoter is inactive, since it contains an intervening 'stuffer' sequence flanked by two loxP sites. The mice are bred to a second transgenic line [described in (C)] expressing Cre-recombinase driven by a podocyte-specific promoter. With the expression of Cre-recombinase, the intervening sequence is excised and the promoter becomes active and able to drive shRNA expression and knockdown the expression of the target gene.
with CNF and in nephrin-null mice [20] . Furthermore, nephrin expression is reduced in many human diseases and in animal models of podocyte injury.
Fyn and Nck
Accumulating evidence suggests that nephrin offers not only a structural contribution to filtration barrier, but can mediate signal transduction from the slit diaphragm in the podocytes [21] . The intracellular domain of nephrin, which contains six conserved tyrosine residues, is phosphorylated by the Src-family kinase Fyn. Phosphorylation of nephrin by Fyn greatly enhanced its association with the slit diaphragm protein podocin and significantly augmented downstream signalling through activation of the AP-1 promoter [22] . Fyn-null mice did not exhibit proteinuria, but exhibited subtle morphological changes within their foot processes [23] . Concomitant deletion of Fyn and the Src-family kinase Yes led to proteinuria, endothelial swelling and podocyte foot process effacement, suggesting at least some level of redundancy and requirement for Src kinases [23] . More recently, two independent groups provided evidence that phosphorylation of nephrin by Fyn recruits the adapter protein Nck, which then leads to actin re-organization [24, 25] . The relevance of Nck recruitment in vivo was demonstrated by podocyte-specific deletion of Nck in transgenic mice; these mice displayed defects in foot process formation leading to congenital nephrotic syndrome. These exciting findings provide evidence that the slit diaphragm can trigger intracellular signalling pathways that mediate cytoskeletal dynamics. Future studies will undoubtedly move further downstream of the slit diaphragm and focus on the roles played by the various signalling cascades in the podocyte.
Podocin
Podocin, the protein encoded by the NPHS2 gene, is an integral membrane protein which binds to nephrin. Podocin was identified by positional cloning and is mutated in patients with autosomal-recessive steroidresistant nephrotic syndrome [26] . Podocin-null mice develop severe proteinuria and die a few days after birth from renal failure [27] . Podocin displays a short hairpinlike structure with both termini inside the podocyte cytoplasm. Podocin was shown to interact directly with nephrin, and this interaction is enhanced following nephrin phosphorylation [22] . These findings suggest that podocin may act to stabilize nephrin at the slit diaphragm and facilitate out-to-in signalling.
CD2AP
CD2AP is an SH3-containing protein originally identified in T-cells as an adapter between adhesion receptors and the cytoskeleton [28] . CD2AP-null mice were originally generated to assess the role of this protein in the immune system. Indeed, these mice displayed a compromised immune function, but surprisingly they died at 6-7 weeks of age from renal failure [29] . It was then that CD2AP was found to be localized in the podocytes, where it interacts with nephrin. Further studies with CD2AP-heterozygous mice, which are otherwise healthy, revealed a defect in the formation of multivesicular bodies in the podocytes, suggesting a defect in the endocytic pathway [30] . These studies of CD2AP-null mice prompted investigators to search for mutations in human patients with glomerular disease. Accordingly, mutations in the CD2AP gene leading to haplo-insufficiency have been identified in several families with FSGS [30] . Interestingly, compound heterozygous-null CD2AP/Fyn mice are proteinuric and exhibit FSGS lesions [31] . This suggests that the effects of mutations in these genes may combine to promote a common aetiology for glomerular dysfunction.
The Neph family
The Neph proteins (Neph1, Neph2 and Neph3) are transmembrane proteins of the Ig superfamily with a structure similar to that of nephrin. Neph1 is crucial for the integrity of the slit diaphragm, as mice lacking Neph1 exhibit proteinuria and die before the age of 8 weeks [32] . The extracellular domains of Neph1 and Neph2 heterodimerize with nephrin and form homodimers with themselves [33, 34] . Furthermore, all three Neph proteins can bind to the slit diaphragm proteins podocin and ZO-1 [35, 36] . The Neph proteins may therefore be ligands for nephrin or each other within the plane of the slit diaphragm and participate in out-to-in signalling events. Podocyte-specific gene targeting approaches are needed in order to elucidate the roles of Neph2 and Neph3 in filtration barrier integrity.
P-cadherin and FAT
The slit diaphragm spanning the gap between adjacent foot processes shares morphological features with adherens junctions. Indeed, P-cadherin, an adherens junction protein, was detected at cell-cell contacts in cultured podocytes and at the slit diaphragm in situ [37] . P-cadherin is not an essential component of the slit diaphragm, as P-cadherin-null mice do not exhibit a renal phenotype [38] . Another set of adherens junction components, the FAT family, are giant protocadherins with 34 extracellular cadherin-like repeats. FAT1 was isolated from glomerular cDNA using primers for conserved cadherin sequences and the protein co-localized with slit diaphragm components by immunohistochemistry [39] . Unlike P-cadherin, FAT1 is an essential component of the filtration barrier. FAT1-null mice exhibit perinatal lethality caused by loss of glomerular slit junctions and podocyte foot process effacement [40] . More recently, FAT2 has also been identified as a component of the slit diaphragm. Although FAT1 binds to Ena/VASP (vasodilator-stimulated phosphoprotein) and participates in actin dynamics and cell polarity [41] , further research is needed to define the exact role(s) of FAT proteins in maintenance of the glomerular filtration barrier.
ZO-1, MAGI-1 [MAGUK (membrane-associated guanylate kinase) with inverted orientation-1] and JAM4 (junctional adhesion molecule 4)
ZO-1 is a member of the MAGUK family. Within the glomerulus, ZO-1 is predominantly expressed in the podocyte foot processes and is concentrated at the level of the slit diaphragm [42] . Expression levels of ZO-1 may vary following podocyte injury, but its role in the slit diaphragm complex has not been fully elucidated. MAGI-1 is a tight junction protein expressed in the podocytes. MAGI-1 interacts with nephrin [43] and with the cytoskeletal proteins synaptopodin and α-actinin-4, suggesting that it may play a role in linking the slit diaphragm to the podocyte cytoskeleton [44] . MAGI-1 also interacts with JAM4, the significance of which is not yet known. Altered expression of JAM4 was reported in a model of podocyte injury and may be a useful marker of injured podocytes [45] . Further research into these tight junction proteins may uncover novel characteristics and roles of the podocyte slit diaphragm.
TRPC6
TRPC6 is part of the TRP family of cation-selective channels. TRPC6 belongs to a subgroup of calcium-permeable channels responsible for intracellular calcium increases following activation of GPCRs (G-proteincoupled receptors) and receptor tyrosine kinases. Mutations in TRPC6 cause an autosomal-dominant kidney disease termed FSGS [46, 47] . A subset of disease-causing mutations enhance TRPC6-mediated calcium influx following receptor activation by agonists. Furthermore, TRPC6 interacts directly with the slit diaphragm proteins nephrin and podocin, as evidenced by co-immunoprecipitation studies [47] . TRPCs may therefore be key players in mediating the response of the podocyte to slit-diaphragm-induced signals. Undoubtedly, a number of mouse models will probably be developed, including TRPC6-null mice and perhaps transgenic mice with podocyte-specific overexpression of the disease-causing mutant TRPC6 protein. Such mice should facilitate our understanding of this channel in the podocyte.
Podocyte adhesion molecules
The foot processes of the glomerular podocytes are tethered to the underlying GBM by transmembrane adhesion molecules. These podocyte-matrix contacts help preserve the structure of the foot processes. Mutant forms of GBM components, such as collagen IV and laminin, or defects in the expression of podocyte adhesion molecules (α3β1 integrins, and α-and β-dystroglycan) can lead to podocyte injury or loss, and failure of the filtration barrier.
Integrins
Integrins are heterodimeric transmembrane receptors that bind to their ligands in the GBM, anchoring a cell to its underlying matrix. The major integrin expressed on the sole of the foot process is the α3β1 integrin heterodimer. The physiological relevance of podocyte-matrix interactions was illustrated by the development of proteinuria, foot process fusion and podocyte detachment following injection of rodents with anti-(β1 integrin) antibodies [48] . Genetic deletion of α3 integrins in mice yielded a disorganized GBM and podocytes which failed to form mature foot processes [49] . Genetic deletion of β1 integrins in mice is embryonic lethal, as homozygousnull embryos develop to the blastocyst stage but die shortly after implantation [50] . The Cre/loxP approach will probably be very informative if used to ablate β1 integrin from the podocyte. Meanwhile, other research is aimed at elucidating the intracellular signals triggered by integrins and their impact on podocyte function and morphology [see ILK (integrin-linked kinase) below].
α-and β-Dystroglycans
Components of the dystroglycan complex are also expressed in the basal cell membrane of the podocyte foot processes. The dystroglycan complex is known to provide a link between the underlying extracellular matrix and the cytoskeleton. Podocyte injury induced by protamine sulfate and the generation of ROS (reactive oxygen species) led to a disruption of α-dystroglycan-matrix complexes, endocytosis of the liberated receptor and disorganization of the GBM [51] . Furthermore, deglycosylation of α-dystroglycan by ROS led to disruption of the dystroglycan-matrix complex [52] , which may contribute to podocyte detachment in vivo. Further studies using temporal deletion of dystroglycan chains in podocytes may uncover the link between dystroglycan complexes and the actin cytoskeleton and its relevance to podocyte biology.
ILK
Beyond their role as cellular anchors, integrins are also involved in signal transduction. Engagement of integrins by extracellular matrix can trigger intracellular signalling pathways (outside-in signalling), and the adhesive characteristics of integrins can be modified in response to intracellular cues (inside-out signalling). ILK, a serine/ threonine kinase, has emerged as a key mediator of podocyte-matrix interactions. ILK mRNA induction was demonstrated in glomeruli of three different renal diseases characterized by a defective filtration barrier [53] . The involvement of ILK in outside-in signalling was demonstrated by its inhibition in response to fibronectin. Furthermore, overexpression of ILK caused a decrease in integrin-matrix adhesion, illustrating its involvement in inside-out signalling. Following puromycin-induced podocyte injury, ILK induces the nuclear translocation of β-catenin, podocyte detachment, cell proliferation and repression of the slit diaphragm molecules P-cadherin and CD2AP; these effects were blocked by a small molecular inhibitor of ILK [54] . To evaluate further the role of ILK in vivo, mice with Cre-mediated podocytespecific ILK inactivation were generated. These mice developed progressive FSGS and died of renal failure [55] . GBM alterations at the onset of proteinuria were followed by foot process effacement, loss of slit diaphragm and re-localization of α3 integrins into a granular pattern along the GBM. These recent findings suggest that ILK and podocyte-matrix interactions play an essential role in podocyte function.
Cytoskeletal components
The unique architecture of the podocyte is achieved largely through the assembly of an elaborate cytoskeleton. The actin filament bundles of the foot processes are not only responsible for maintaining the shape of the cell, but also connect the slit diaphragm on the lateral sides of the foot processes to the adhesion complexes on the foot process sole. Furthermore, the cytoskeleton may also contribute to counteract the distensile forces of the capillary wall. To carry out these roles, a highly ordered cytoskeleton must provide a balance of structural strength and pliability in order for the podocyte to cope with changes in glomerular capillary pressure as well as being responsive to extracellular stimuli. A growing list of cytoskeletal components accounts for the dynamic nature of the podocyte, some of which are discussed below.
Synaptopodin
Synaptopodin is an actin-associated protein highly expressed in podocyte foot processes and telencephalic dendrites [56] . The observation that synaptopodin expression is restricted to areas of high synaptic plasticity in the brain, along with results from cultured cells, suggested that synaptopodin may play an important role in modulating actin-based shape and motility of cells. Synaptopodin-null mice lack the dendritic spine apparatus, but do not display ultrastructural defects within the podocytes [57] . However, the recovery from chemically induced foot process effacement was impaired in synaptopodin-null mice, highlighting a defect in podocyte cytoskeletal dynamics. Furthermore, the authors [57] showed that synaptopodin regulates the actinbundling activity of α-actinin-4 in highly dynamic areas, such as podocyte foot processes. The involvement of synaptopodin in cytoskeletal dynamics and podocyte motility was supported recently [58] , as gene silencing of synaptopodin in cultured podocytes caused a loss of stress fibres, formation of aberrant filipodia and impaired podocyte migration. Taken together, these findings show that synaptopodin is essential for cytoskeletal dynamics and podocyte migration.
α-Actinin-4
α-Actinin-4, an actin cross-linking protein, is expressed in the foot processes where it is responsible for bundling longitudinal actin fibres. Mutations in the ACTN4 gene cause a late-onset autosomal dominant form of FSGS [59] . A subset of FSGS mutations located just outside the actinbinding domain increases the affinity of α-actinin-4 for actin, suggesting that the podocyte cytoskeleton may be dysregulated. In mice, podocyte-specific expression of a high-affinity variant of α-actinin-4 caused proteinuria, foot process effacement and glomerular sclerosis [60] . Consistent with such podocyte damage, transgenic kidneys exhibited significantly reduced mRNA and protein levels of the slit diaphragm component nephrin. Genetic deletion of α-actinin-4 in mice or replacement of the endogenous ACTN4 gene with copies harbouring a disease-associated mutation leads to a similar phenotype, characterized by proteinuria and the onset of glomerular disease [61, 62] . A fraction of FSGS-associated α-actinin-4 was found to form large aggregates, which in turn target the protein for degradation via the ubiquitin-proteasome pathway. In contrast, our laboratory has discovered that gain-of-affinity mutations in α-actinin-4 confer mislocalization of the protein in cultured podocytes, which adversely affects cytoskeletal dynamics and podocyte motility [62a] . Taken together, these findings clearly indicate that the cytoskeleton plays a crucial role in the structure of podocytes and that a dynamic cytoskeleton is required for podocyte dynamics.
Other podocyte molecules
In addition to the myriad of slit diaphragm components, adhesion molecules and cytoskeletal proteins described above, several other proteins that are required for podocyte form and function have been described. Many of these proteins are expressed on the apical membrane of the podocytes and their function ranges from generation of a charged glycocalyx to intracellular signalling.
Podocalyxin
Podocalyxin, a sialomucin, is the major sialoglycoprotein expressed in podocytes and is responsible for generating a negative charge on the surface of the podocyte [63] . It is thought that the negative charge of podocalyxin helps repel proteins from passing through the GBM and serves as a spacer between adjacent foot processes. The cytoplasmic domain of podocalyxin interacts with two cytosolic adapter proteins, ezrin and NHERF2 (Na + /H + exchanger-regulatory factor 2), providing a link to the actin cytoskeleton [64] . Disruption of podocalyxin-NHERF2-ezrin interactions in pathological conditions associated with changes in foot process structure provides evidence of its relevance in vivo. Furthermore, podocytes of podocalyxin-null mice fail to form foot processes and the slit diaphragm is replaced by tight and adherens junctions; these mice die within 24 h of birth from anuric renal failure [65] . It was demonstrated later that podocalyxin activates RhoA, a small-GTPase, through NHERF and ezrin, leading to a redistribution of actin filaments [66] . Taken together, these results indicate that podocyalyxin is essential for the formation of the filtration barrier and that podocalyxin may mediate signals affecting the cytoskeletal organization of the foot processes.
GLEPP1 (glomerular epithelial protein 1)
A candidate for cytoskeletal regulation in the podocyte is GLEPP1, a podocyte-specific receptor tyrosine phosphatase. In mice, GLEPP1 is first expressed at the capillary loop stage of glomerular development and persists at high levels in fully developed glomeruli. GLEPP1-null mice do not exhibit proteinuria, but podocytes display morphological changes, such as broadening of the foot processes [67] . Since no ligand or substrates have been described for GLEPP1, its exact function in glomerular filtration remains unknown.
Rho GDIα (GDP dissociation inhibitor α)
Members of the Rho family of small GTPases are important mediators of actin cytoskeleton re-organization leading to changes in morphology, adhesion and motility. Rho GTPases cycle between their active GTP-bound and inactive GDP-bound states. Rho GDIα is a negative regulator of Rho, keeping it in its inactive GDPbound state within the cytosol. The involvement of Rho in podocyte cytoskeletal dynamics was illustrated by the development of massive proteinuria and nephrotic syndrome in Rho GDIα-null mice [68] . Since Rho participates in the formation of actin fibres, uncontrolled formation and bundling of actin filaments most probably impairs cytoskeletal dynamics and foot process structure.
WT1 (Wilms' tumour suppressor 1)
WT1 protein is a key transcription factor involved in podocyte function. WT1 is a zinc-finger transcription factor that is required for podocyte maturation, but remains highly expressed into adulthood. Dominant mutations in the WT1 gene cause Denys-Drash syndrome and Frasier's syndrome, both characterized by progressive glomerulopathy and male pseudohermaphroditism. Disruption of the WT1 gene in mice is embryonic lethal owing to the failure of kidney and gonad development. Heterozygous mice (WT1 +/− ) appear normal during early stages of life, but develop adult-onset nephrotic syndrome with mesangial sclerosis [69] . The WT1 gene is very complex; alternative start sites, alternative splicing and RNA editing can result in at least 24 different isoforms [70] . Alternative splice donor sites in exon 9 can lead to the lack of a three amino acid sequence (lysine, threonine and serine) termed the KTS motif [71] . Homozygous mice lacking the −KTS variant die shortly after birth and display hypoplastic kidneys and streak gonads, indicating a role for the WT1 (−KTS) variant in embryonic kidney and gonad survival. Similarly, homozygous mice lacking the +KTS variant also die shortly after birth, but display reduced podocyte differentiation and XY sex reversal. Heterozygous mice with reduced expression levels of the +KTS variant develop glomerulosclerosis and represent a model of Frasier's syndrome. Podocytespecific genes that may be targets of WT1 are beginning to emerge. Binding of WT1 to conserved elements within the podocalyxin gene promoter results in potent transcriptional activation [72] . Furthermore, WT1 may be required for regulation of the NPHS1 gene and the intermediate filament protein nestin [73] . Further studies are clearly needed in order to define the physiological roles of the numerous WT1 isoforms and their relevance to podocyte biology.
SPARC (secreted protein acidic and rich in cysteine)
Elevated intraglomerular pressure is a common occurrence in many renal disorders and promotes podocyte injury and glomerulosclerosis. Increased mechanical strain on the podocytes can initiate maladaptive responses, such as apoptosis and podocyte detachment from the extracellular matrix. SPARC is a matricellular protein with antiproliferative effects in various tissues. SPARC is activated following complement-mediated podocyte injury [74] . SPARC-null mice are less sensitive to STZ (streptozotocin)-induced diabetic nephropathy, illustrating further the deleterious effects of SPARC activation on podocytes [75] . In cultured podocytes, mechanical strain increases both intracellular and secreted levels of SPARC, whereas experimental glomerular hypertension increases podocyte SPARC levels in vivo [76] . Taken together, these results suggest that SPARC activation promotes podocyte injury and the development of glomerulosclerosis.
VEGF (vascular endothelial growth factor)
VEGF is a growth factor involved in angiogenesis. VEGF can regulate vascular permeability, endothelial cell migration, proliferation and survival. Within the glomerulus, VEGF is expressed on podocytes, whereas its receptors (VEGFR1/Flt-1 and VEGFR2/Flk-1) are expressed on endothelial cells, suggesting that VEGF functions in juxtacrine/paracrine signalling pathways [77] . Elegant genetic studies have illustrated an exquisite dosagesensitivity for VEGF within the glomerulus [78] . Homozygous VEGF-null mice die during embryogenesis from failed vascularization. Podocyte-specific deletion of one VEGF allele leads to proteinuria and endotheliosis, whereas deletion of both VEGF alleles resulted in perinatal lethality and the absence of a filtration barrier due to defects in endothelial cell migration, differentiation and survival. Furthermore, podocyte-specific overexpression of VEGF causes collapsing glomerulopathy. These results demonstrate that VEGF signalling is critical for the formation of a functional filtration barrier. In a recent study [79] , VEGF production by the podocyte was also shown to be required for mesangial cell migration and survival. Numerous studies have shown that VEGF is indispensable for glomerular capillary growth; however, the role of sustained VEGF expression following nephrogenesis is not clearly defined. Conditionally immortalized glomerular endothelial cells have recently been described [80] ; these cells demonstrate fenestrations, which increase strikingly in number following stimulation with VEGF. These results suggest that podocyte-derived VEGF may play a key role in maintaining endothelial fenestrations within the glomerulus. Further studies are needed to elucidate the signalling pathways triggered by VEGF and its receptors.
GPCRs and Gαq
A role of the RAS (renin-angiotensin system) in modulating podocyte function in disease has been implied by numerous studies showing that ACE inhibition can blunt albuminuria in many glomerular disease states [81] [82] [83] [84] . Although the source and actions of angiotensin II in the pathogenesis of glomerular disease remain incompletely resolved, cell culture studies of conditionally immortalized podocytes revealed the presence of the major members of the RAS, including AT1 (angiotenin II type 1) receptors and ACE [85] . It is thought that enhanced intraglomerular capillary pressure and AT1 receptor activity combine to drive the podocyte along an apoptotic pathway, thereby damaging the glomerular filter and contributing towards a sclerotic phenotype, according to the hypothesis of Kriz and Lehir [86] . Although podocytespecific deletion of the AT1 receptor (or ACE) in mice awaits investigation, transgenic rats overexpressing the human AT1 receptor under the control of the nephrin promoter exhibit several defects in podocyte function, including effacement, pseudocyst formation and detachment from the GBM, all of which result in significant albuminuria by 8 weeks of age [87] . The AT1 receptor is a member of the GPCR superfamily and signals from the cell surface via the Gq protein to activate phospholipase C. Transgenic mice bearing podocyte-specific expression of a constitutively active Gαq subunit were recently generated [88] . These mice developed albuminuria along with reduced renal mass and nephron number coupled with diminished expression of podocalyxin and nephrin and, eventually, exhibited FSGS lesions. Additionally, the susceptibility of such mice to glomerular injury with puromycin aminonucleoside was increased. These findings strongly suggest that GPCR-induced signalling in the podocyte may contribute to the early damage seen in at least some glomerular diseases. However, additional studies are needed to investigate the roles played by the numerous GPCRs expressed by the podocyte as they respond to their relevant ligands.
CONCLUSIONS AND OUTLOOK
Targeting and modification of genes in mice and rats has greatly facilitated the study of gene function in vivo. The application of these powerful techniques to the podocyte has provided invaluable information about the complexity of this essential cell type in its role as a central player in the maintenance of the glomerular filtration barrier. Undoubtedly, future studies will continue to advance our knowledge of the podocyte as more rodent models are developed to complement the wealth of biochemical-, cell biological-, genomic-and proteomicbased approaches that together will lead towards a more comprehensive appreciation of this fascinating cell type and its role in health and disease.
